| Podcast
Developed by the American Headache Society®, the Chronic Migraine Education Program (CMEP) includes new advances and addresses acute and preventive treatment options. In addition, the CMEP highlights epidemiologic data on the scope and distribution of migraine with an emphasis on diagnosing chronic...
| Podcast
Developed by the American Headache Society®, the Chronic Migraine Education Program (CMEP) includes new advances and addresses acute and preventive treatment options. In addition, the CMEP highlights epidemiologic data on the scope and distribution of migraine with an emphasis on diagnosing chronic...
| Article
Newswise — Migraine sufferers who used a smartphone-based relaxation technique at least twice a week experienced on average four fewer headache days per month, a new study shows.
Developed in part by researchers at NYU School of Medicine, the app, called RELAXaHEAD, guides patients through...
| Article
Newswise—June is migraine and headache awareness month. Migraine affects more than 38 million Americans and is the third most common condition worldwide. Despite such a vast number of sufferers, however, significant development of migraine treatment options continue to lag.
According to Regina...
| Video
Dr. Jay discusses an emerging class of medications that represents a paradigm shift in the treatment of migraine: CGRP receptor antagonists. But there’s more to managing migraine than just the medication…
| Article
In an article published last month in PloS One, researchers studying 155 outpatients with major depressive disorder found that “Compared with the migraine with inactive headache group and the non-migraine group, patients with migraine with active headache had significantly higher intensities of...
| Article
The incidence of migraine is 3 times higher in women than in men, and findings from a recent preclinical study conducted at the University of Texas, Dallas may shed light on the reason why. Working with rodent models, researchers introduced calcitonin gene-related peptide (CGRP), a protein...
| Article
Findings from a recently completed meta-analysis suggest that obese migraine sufferers can reduce the incidence and severity of migraine attacks and improve their quality of life by losing weight. Lead author Claudio Pagano, MD, PhD, associate professor of internal medicine at the University of...
| Video
Migraine is among the most disabling disorders in the world, and much of the treatment armamentarium to date comes with significant unwanted effects. But new advances in our understanding of neurotransmitters and sensory processing may have led us to the dawn of a new and better era of migraine...
| Article
Botulinum toxin, usually referenced by the brand name Botox®, received FDA approval as a treatment for chronic migraine in 2010. An updated review and meta-analysis of pooled clinical trial data now provides further confirmation of its efficacy, concluding that Botox is superior to placebo for the...